BACKGROUND: To prospectively assess the clinical value of stress-gated myocardial single photon emission computed tomography (SPECT) for triaging patients admitted through the emergency department (ED) with acute chest pain (ACP). METHODS: Prospective, observational cohort study in 1,576 consecutive patients who were evaluated for ACP over a 29-month period. Stress SPECT was performed within 24 hours of admission from the ED. Analysis included quantification of total and ischemic left ventricular perfusion defect size (PDS). Cardiac events were defined as an acute coronary syndrome during the index hospitalization or in follow-up over 7.3 ± 2.8 months. RESULTS: Eighty-five cardiac events occurred in 77 patients (4.9%). SPECT was abnormal in 135 patients (8.6%) of whom 83 (61.5%) had a reversible defect. Event rates were significantly higher in patients with an abnormal (40%) versus a normal (1.6%) SPECT (P < .0001); and in those with a (1) large (>15%) versus small (≤15%) PDS (50.0% vs 33.7%, P = .05) and (2) large (>10%) versus small (≤10%) ischemic PDS (87.5% vs 42.4%, P < .0001, respectively). SPECT best predicted cardiac events by multivariate analysis. The addition of SPECT to clinical variables significantly improved overall risk prediction (global χ(2) 103.6 vs 207.1, P < .001). CONCLUSIONS: Stress SPECT can accurately assess risk in a heterogeneous group of patients with ACP of unclear cardiac etiology, and beyond that provided by a clinical risk assessment alone. Our results support the use of stress SPECT for identifying very low-risk ACP patients with normal study results who can be safely discharged home.
BACKGROUND: To prospectively assess the clinical value of stress-gated myocardial single photon emission computed tomography (SPECT) for triaging patients admitted through the emergency department (ED) with acute chest pain (ACP). METHODS: Prospective, observational cohort study in 1,576 consecutive patients who were evaluated for ACP over a 29-month period. Stress SPECT was performed within 24 hours of admission from the ED. Analysis included quantification of total and ischemic left ventricular perfusion defect size (PDS). Cardiac events were defined as an acute coronary syndrome during the index hospitalization or in follow-up over 7.3 ± 2.8 months. RESULTS: Eighty-five cardiac events occurred in 77 patients (4.9%). SPECT was abnormal in 135 patients (8.6%) of whom 83 (61.5%) had a reversible defect. Event rates were significantly higher in patients with an abnormal (40%) versus a normal (1.6%) SPECT (P < .0001); and in those with a (1) large (>15%) versus small (≤15%) PDS (50.0% vs 33.7%, P = .05) and (2) large (>10%) versus small (≤10%) ischemic PDS (87.5% vs 42.4%, P < .0001, respectively). SPECT best predicted cardiac events by multivariate analysis. The addition of SPECT to clinical variables significantly improved overall risk prediction (global χ(2) 103.6 vs 207.1, P < .001). CONCLUSIONS: Stress SPECT can accurately assess risk in a heterogeneous group of patients with ACP of unclear cardiac etiology, and beyond that provided by a clinical risk assessment alone. Our results support the use of stress SPECT for identifying very low-risk ACP patients with normal study results who can be safely discharged home.
Authors: James A Goldstein; Michael J Gallagher; William W O'Neill; Michael A Ross; Brian J O'Neil; Gilbert L Raff Journal: J Am Coll Cardiol Date: 2007-02-12 Impact factor: 24.094
Authors: Robert E O'Connor; William Brady; Steven C Brooks; Deborah Diercks; Jonathan Egan; Chris Ghaemmaghami; Venu Menon; Brian J O'Neil; Andrew H Travers; Demetris Yannopoulos Journal: Circulation Date: 2010-11-02 Impact factor: 29.690
Authors: Su Min Chang; Faisal Nabi; Jiaqiong Xu; Leif E Peterson; Arup Achari; Craig M Pratt; John J Mahmarian Journal: J Am Coll Cardiol Date: 2009-11-10 Impact factor: 24.094
Authors: E Gordon Depuey; John J Mahmarian; Todd D Miller; Andrew J Einstein; Christopher L Hansen; Thomas A Holly; Edward J Miller; Donna M Polk; L Samuel Wann Journal: J Nucl Cardiol Date: 2012-04 Impact factor: 5.952
Authors: Swee Han Lim; Venkataraman Anantharaman; Felix Sundram; Edwin Shih-Yen Chan; Ee Sin Ang; Sui Lan Yo; Edward Jacob; Anthony Goh; Say Beng Tan; Terrance Chua Journal: J Nucl Cardiol Date: 2013-09-13 Impact factor: 5.952
Authors: John J Mahmarian; Leif E Peterson; Jiaqiong Xu; Manuel D Cerqueira; Ami E Iskandrian; Timothy M Bateman; Gregory S Thomas; Faisal Nabi Journal: J Nucl Cardiol Date: 2014-10-07 Impact factor: 5.952
Authors: Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti Journal: Arq Bras Cardiol Date: 2020-02 Impact factor: 2.000
Authors: Grace Ronan; Michael J Wolk; Steven R Bailey; John U Doherty; Pamela S Douglas; Robert C Hendel; Christopher M Kramer; James K Min; Manesh R Patel; Lisa Rosenbaum; Leslee J Shaw; Raymond F Stainback; Joseph M Allen; Ralph G Brindis; Christopher M Kramer; Leslee J Shaw; Manuel D Cerqueira; Jersey Chen; Larry S Dean; Reza Fazel; W Gregory Hundley; Dipti Itchhaporia; Paul Kligfield; Richard Lockwood; Joseph Edward Marine; Robert Benjamin McCully; Joseph V Messer; Patrick T O'Gara; Richard J Shemin; L Samuel Wann; John B Wong; Manesh R Patel; Christopher M Kramer; Steven R Bailey; Alan S Brown; John U Doherty; Pamela S Douglas; Robert C Hendel; Bruce D Lindsay; James K Min; Leslee J Shaw; Raymond F Stainback; L Samuel Wann; Michael J Wolk; Joseph M Allen Journal: J Nucl Cardiol Date: 2014-02 Impact factor: 5.952